Ligand profile
ZINC2541692
Virtual-screening candidate from ZINC.
Bound to: VK055_4925 — apurinic endonuclease family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC2541692- UniProt (similar protein)
P0A6C1- Tanimoto
- 1.000
- Target protein
- VK055_4925
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 98.5
- −1 ≤ LogP ≤ 5 1.90
- MW ≤ 500 Da 402.4
- LogP ≤ 5 1.90
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 9
- TPSA ≤ 140 Ų 98.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
NC(=O)COc1c(F)cc(SCCNS(=O)(=O)c2ccccc2)cc1FNC(=O)COc1c(F)cc(SCCNS(=O)(=O)c2ccccc2)cc1F
InChI=1S/C16H16F2N2O4S2/c17-13-8-11(9-14(18)16(13)24-10-15(19)21)25-7-6-20-26(22,23)12-4-2-1-3-5-12/h1-5,8-9,20H,6-7,10H2,(H2,19,21)InChI=1S/C16H16F2N2O4S2/c17-13-8-11(9-14(18)16(13)24-10-15(19)21)25-7-6-20-26(22,23)12-4-2-1-3-5-12/h1-5,8-9,20H,6-7,10H2,(H2,19,21)
GTACSIONMHMRPD-UHFFFAOYSA-NGTACSIONMHMRPD-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- P99
- Homolog
- P0A6C1
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC2541692 →
- ZINC ZINC20 ZINC2541692 →
- UniProt UniProt P0A6C1 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC2541692”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4925.
ChEMBL 64
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).